RSV Vaccine

A Phase 3 Study to Evaluate The Efficacy, Immunogenicity, and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Subunit (Vaccine)

Sign Up For A Study

Study Information

Condition

RSV Vaccine

Phase III

VACCINE IN ADULTS

  • Healthy volunteers
  • mRNA vaccine

Conquest Research needs volunteers for an RSV Vaccine trial evaluating a medication designed for the prevention of Respiratory Syncytial Virus. You may qualify if you:

  • Are over 60 years old

  • Have not gotten a previous RSV vaccine

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

Sign Up For A Study

    What To Expect

    PATIENT RESOURCES & FAQ

    Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

    SEE MORE
    A mature medical doctor smiling as some of his colleagues stand in the background

    Register For A Study!

    Register